has been cited by the following article(s):
[1]
|
Validated Kinetic Spectrophotometric Methods to Optimize Robustness Study with Youden Factorial Combinations to Determine Repaglinide Using Response Surface Methodology via Box–Behnken Design
Arabian Journal for Science and Engineering,
2023
DOI:10.1007/s13369-022-06782-w
|
|
|
[2]
|
Progress in Analytical Techniques for Remogliflozin Etabonate, Vildagliptin
And Metformin Hydrochloride: A Recently, Approved FDC
Current Pharmaceutical Analysis,
2023
DOI:10.2174/1573412919666221025103613
|
|
|
[3]
|
Development of a Simple Isocratic HPLC-UV Method for the Simultaneous Analysis of Repaglinide and Metformin Hydrochloride in Nanoemulsion Formulations and Commercial Tablets
Pharmaceutical Chemistry Journal,
2023
DOI:10.1007/s11094-023-02884-3
|
|
|
[4]
|
Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC
Pharmaceutics,
2022
DOI:10.3390/pharmaceutics14061187
|
|
|
[5]
|
Validated Kinetic Spectrophotometric Methods to Optimize Robustness Study with Youden Factorial Combinations to Determine Repaglinide Using Response Surface Methodology via Box–Behnken Design
Arabian Journal for Science and Engineering,
2022
DOI:10.1007/s13369-022-06782-w
|
|
|
[6]
|
Q-Absorbance Ratio Spectrophotometric Method for the Simultaneous Estimation of Metformin Hydrochloride and Voglibose in Tablet Dosage form
Research Journal of Pharmacy and Technology,
2021
DOI:10.52711/0974-360X.2021.00554
|
|
|